A Phase II, Single Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and the Therapeutic Effectiveness of Rapid Acting Insulin in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer’s Disease (2012)